2021 – 2023 Clinical Investigator Award for Under-Represented BIPOC Surgeons Call for Proposals
Proposals must be submitted electronically and via hard copy by Monday, February 8, 2021. For additional information on Award criteria and the application process, click the link below.
2021 – 2023 Clinical Investigator Award for Under-Represented (BIPOC) Surgeons Criteria & Application Process
Supported by Genentech
Applicants must be surgical oncologists within 8 years of completion of training.
Be full SSO members for at least 6 months prior to application submission to be eligible for the award.
Identify race/ethnicity as one of the following (categories based on SSO’s member profile demographics:
American Indian/Alaska Native
Hawaiian Pacific Islander
Effective in 2014, it is no longer necessary for the applicant to commit at least 25% effort to the research project this award will support. Time committed should be reflected in the research proposal budget and will be taken into consideration as part of the overall assessment of the project.
Terms of the Award
The award will be funded for two years at $100,000 ($50,000 per year) beginning April 1, 2021.
The award is given to the sponsoring institution and may be used for partial support of applicant’s salary, research fellows or staff support, tuition, travel (no more than $2,000 per year) and/or supplies. No additional funds are available for paying indirect costs. Please refrain from including indirect costs in the project budget.
A brief year-one progress report with a financial update will be required by March 31, 2022. SSO reserves the right to withhold the second year of support in the event of unsatisfactory progress.
A final report (not to exceed 4 pages) will be required before February 15, 2023. This should include a summary of the project and abstracts and publications acknowledged as supported by this award as well as a financial reconciliation report.
A brief (up to 10 minutes) presentation of results may be required at the SSO 2023 International Conference on Surgical Cancer Care, scheduled for March 2023.